Check Cap Ltd (NASDAQ:CHEK)’s share price shot up 71.9% during mid-day trading on Thursday . The company traded as high as $3.35 and last traded at $2.39, with a volume of 5,375,764 shares traded. The stock had previously closed at $1.39.

A number of research firms have issued reports on CHEK. Chardan Capital reduced their price target on shares of Check Cap from $6.00 to $4.00 and set a “buy” rating for the company in a research report on Friday, May 20th. Maxim Group reissued a “buy” rating on shares of Check Cap in a research report on Thursday, May 19th. Finally, Zacks Investment Research raised shares of Check Cap from a “hold” rating to a “buy” rating and set a $1.50 price target for the company in a research report on Tuesday, June 14th.

The firm’s 50-day moving average is $1.28 and its 200-day moving average is $2.22. The stock’s market capitalization is $32.40 million.

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.